ARTICLE II. REPRESENTATIONS AND WARRANTIESWarrant Exercise Agreement • May 4th, 2007 • Rand Logistics, Inc. • Water transportation • New York
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 16th, 2019 • Genius Brands International, Inc. • Services-motion picture & video tape production
This Warrant Exercise Agreement (this “Agreement”), dated as of December 16, 2019, is by and between Genius Brands International, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, no par value (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • August 20th, 2018 • Amyris, Inc. • Industrial organic chemicals • New York
This Warrant Exercise Agreement (this “Agreement”) is dated as of August 17, 2018 (the “Effective Date”), among Amyris, Inc., a Delaware corporation (the “Company”) and the undersigned investor (the “Holder”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 23rd, 2021 • Can-Fite BioPharma Ltd. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of December 20, 2021, is by and between Can-Fite BioPharma Ltd., an Israeli company (the “Company”), and the undersigned holder (each, a “Holder” and, collectively, the “Holders”) of Series A warrants to purchase ordinary shares of the Company, par value NIS 0.25 per share (the “Ordinary Shares”), represented by American Depositary Shares issued by the Company, which warrants were issued on August 16, 2021 and are exercisable at an exercise price of $2.00 per ADS, (the “Original Warrants”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 29th, 2019 • Biocept Inc • Services-medical laboratories
This Warrant Exercise Agreement (this “Agreement”), dated as of May 28, 2019, is by and between Biocept, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • July 23rd, 2021 • Vinco Ventures, Inc. • Games, toys & children's vehicles (no dolls & bicycles) • New York
This WARRANT EXERCISE AGREEMENT (the “Agreement”), dated as of June ___, 2021, is made by and between Vinco Ventures, Inc., a Nevada corporation, with headquarters located at 1 West Broad Street, Suite 1004, Bethlehem, Pennsylvania 18018 (the “Company”), and the investor listed on the signature page attached hereto (the “Holder”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the applicable Warrants (as defined below).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 20th, 2021 • Vinco Ventures, Inc. • Games, toys & children's vehicles (no dolls & bicycles) • New York
This WARRANT EXERCISE AGREEMENT (the “Agreement”), dated as of December 20, 2021, is made by and between Vinco Ventures, Inc., a Nevada corporation, with headquarters located at 6 North Main Street, Fairport, NY 14450 (the “Company”), and the investor listed on the signature page attached hereto (the “Holder”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the applicable Warrants (as defined below).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • July 26th, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances
This Warrant Exercise Agreement (this “Agreement”) is entered into as of July 21, 2017, by and among OncoCyte Corporation, a California corporation (the “Company”), and [●] (the “Holder”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 12th, 2018 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of December 11, 2018, is by and between Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of a Common Stock Purchase Warrant to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), issued by the Company, which warrant is exercisable at an exercise price (the “Exercise Price”) of $.40 per share (the “Original Warrant”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 13th, 2022 • Vinco Ventures, Inc. • Games, toys & children's vehicles (no dolls & bicycles) • New York
This WARRANT EXERCISE AGREEMENT (the “Agreement”), dated as of May 12, 2022, is made by and between Vinco Ventures, Inc., a Nevada corporation, with headquarters located at 6 North Main Street, Fairport, NY 14450 (the “Company”), and CVI Investments, Inc. (the “Holder”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Series A September 2021 Warrants (as defined below).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • October 14th, 2020 • Applied Dna Sciences Inc • Services-miscellaneous business services
This Warrant Exercise Agreement (this “Agreement”), dated as of October 7, 2020, is by and between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • February 19th, 2020 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of February 14, 2020, is by and between Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the undersigned holder (each, a “Holder” and, collectively, the “Holders”) of warrants to purchase shares of common stock of the Company, par value $0.001 per share (the “Common Stock”), at an exercise price of $0.77 per share, issued by the Company on September 27, 2019 in connection with its underwritten public Offering (the “September 2019 Warrants”) and warrants to purchase Common Stock, at an exercise price of $2.86 per share, issued by the Company on March 29, 2018 (the “March 2019 Warrants”, and together with the September 2019 Warrants, the “Original Warrants”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • March 9th, 2021 • Opgen Inc • Services-medical laboratories
This Warrant Exercise Agreement (this “Agreement”), dated as of March 9, 2021, is by and between OpGen, Inc., a Delaware corporation (the “Company”), and the undersigned holders (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”).
EX-10.1 2 f8k032318ex10-1_aytubio.htm FORM OF WARRANT EXERCISE AGREEMENT WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 5th, 2020 • New York
THIS WARRANT EXERCISE AGREEMENT (the “Agreement”) is dated as of March 23, 2018, by and between AYTU BIOSCIENCE, INC., a Delaware corporation (the “Company”), and _______________________ (the “Investor”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • July 14th, 2017 • Reed's, Inc. • Bottled & canned soft drinks & carbonated waters
THIS WARRANT EXERCISE AGREEMENT (this “Agreement”), dated as of July 13, 2017, is by and between Reed’s, Inc., a Delaware corporation (the “Company”) and Raptor/Harbor Reeds SPV LLC, a Delaware limited liability company (the “Holder”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • October 29th, 2019 • Sesen Bio, Inc. • Pharmaceutical preparations
THIS WARRANT EXERCISE AGREEMENT (this “Agreement”), dated as of October 28, 2019, is by and between Sesen Bio, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • January 10th, 2012 • CAPSTONE TURBINE Corp • Engines & turbines • New York
This Warrant Exercise Agreement (the “Agreement”), dated January 9, 2012, relates to Warrant Number [ ] dated January 24, 2007 (the “Warrant”) issued by Capstone Turbine Corporation, a Delaware corporation (the “Company”), to [ ] (the “Holder”), pursuant to which the Holder is entitled to subscribe for and purchase up to [ ] shares (the “Warrant Shares”) of the common stock, par value $0.001 per share, of the Company (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • January 23rd, 2020 • Genius Brands International, Inc. • Services-motion picture & video tape production
This Warrant Exercise Agreement (this “Agreement”), dated as of January 22, 2020, is by and between Genius Brands International, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”).
EX-10.4 10 d534822dex104.htm EX-10.4 Execution Version WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 5th, 2020 • Delaware
This Warrant Exercise Agreement (this “Agreement”), dated as of March 8, 2018, is by and between Alphatec Holdings, Inc., a Delaware corporation (“Company”), and Armistice Capital Master Fund, Ltd. (“Holder”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • February 24th, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances
This Warrant Exercise Agreement (this “Agreement”) is entered into as of February 17, 2017, by and among OncoCyte Corporation, a California corporation (the “Company”), and [·] (the “Holder”).
EX-10.1 4 genius_ex1001.htm FORM OF WARRANT EXERCISE AGREEMENT WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 5th, 2020
This Warrant Exercise Agreement (this “Agreement”), dated as of February 9, 2017, is by and between Genius Brands International, Inc. a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued by the Company, which warrant is exercisable until November 3, 2020 at an exercise price (the “Exercise Price”) of $3.30 per share (the “Original Warrant”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • August 2nd, 2019 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
This Warrant Exercise Agreement (this “Agreement”), dated as of August 2, 2019, is by and among Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and the undersigned holder of a Common Stock Purchase Warrant (the “Existing Warrant”) issued by the Company on June 6, 2018 (the “Holder”).
Re: Series B and C Warrant Exercise AgreementWarrant Exercise Agreement • May 31st, 2024 • Calidi Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Calidi Biotherapeutics, Inc. (the “Company”) previously issued and delivered to you (“Holder” or “you” or “your”) the Company’s (i) Series B unit purchase warrants (the “Series B Warrants”) to purchase units (the “Series B Units”) consisting of: (i) shares of the Company’s voting common stock, par value $0.0001 per share (“Common Stock”) and Series B-1 warrants to purchase Common Stock (the “Series B-1 Warrants”) and (ii) Series C unit purchase warrants (the “Series C Warrants”) to purchase units (the “Series C Units”) consisting of: (i) shares of Common Stock and (ii) Series C-1 warrants to purchase Common Stock (the “Series C-1 Warrants”), both of which were issued to you pursuant to a Securities Purchase Agreement, dated April 16, 2024 (the “Purchase Agreement”) and the prospectus dated April 15, 2024.
Exhibit 4.9 June 9, 1998 Via Facsimile (913-642-8661) Josh Selzer Jayhawk Investments, LP Jayhawk Institutional Partners, LP 8201 Mission Road, Suite 110 Prairie Village, Kansas 66208 Re: Exercise of Warrants/Issuance of Common Stock Dear Josh: This...Warrant Exercise Agreement • August 14th, 1998 • Syquest Technology Inc • Computer storage devices
June 3, 1998Warrant Exercise Agreement • August 14th, 1998 • Syquest Technology Inc • Computer storage devices
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • June 10th, 2016 • BTCS Inc. • Services-prepackaged software • New York
THIS WARRANT EXERCISE AGREEMENT (the “Agreement”), dated as of June 8, 2016, is being executed and delivered by and between BTCS Inc. (formerly Bitcoin Shop, Inc.), a Nevada corporation (“BTCS”), and the undersigned warrant holder (the “Holder”) in order to amend set forth the terms of the Holder’s irrevocable exercise of that certain warrant to purchase 2,325,000 shares (the “Warrant Shares”) of BTCS’ common stock that was originally issued on January 19, 2015 (the “Warrant”), which Warrant is held by the Holder.
EXHIBIT 10.2 March 31, 1998 Via Facsimile Moishe Bodner Combination, Inc. 310 Madison Avenue, Suite 501 New York, New York 10017 Re: Exercise of Warrants/Issuance of Common Stock Dear Moishe: This letter confirms the agreement (the "Letter Agreement")...Warrant Exercise Agreement • April 10th, 1998 • Syquest Technology Inc • Computer storage devices
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • November 14th, 2017 • GT Biopharma, Inc. • Pharmaceutical preparations • New York
This Warrant Exercise Agreement (this “Agreement”) is entered into as of August 29, 2017, by and among GT Biopharma, Inc., a Delaware corporation (the “Company”), and the parties listed on Schedule A hereto (the “Warrant Holders” or Holders”).
WARRANT EXERCISE AGREEMENT --------------------------Warrant Exercise Agreement • April 10th, 1998 • Syquest Technology Inc • Computer storage devices • Illinois
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 7th, 2020 • Meten EdtechX Education Group Ltd. • Services-educational services • New York
This WARRANT EXERCISE AGREEMENT (this “Agreement”) is entered into as of December 4, 2020, by and between Meten EdtechX Education Group Ltd., a Cayman Islands exempted company listed on the NASDAQ (stock symbol METX) (the “Company”), IBIS CAPITAL SPONSOR LLC (“IBIS”) and IBIS CAPITAL SPONSOR II LLC (“IBIS II”, collectively with IBIS, the “Sponsors”). Capitalized terms used but not defined herein shall have the same meanings ascribed to them in the Warrant Agreement (as defined below).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • June 28th, 2013 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
This WARRANT EXERCISE AGREEMENT dated as of June 25, 2013 (this “Agreement”) is made by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Platinum-Montaur Life Sciences, LLC, a Delaware limited liability company (the “Investor”).
AGREEMENTWarrant Exercise Agreement • December 23rd, 1999 • Bion Environmental Technologies Inc • Misc industrial & commercial machinery & equipment
PROSPECT GLOBAL RESOURCES INC. SERIES A WARRANT EXERCISE AGREEMENT (this “Agreement”) February 11, 2014Warrant Exercise Agreement • February 12th, 2014 • Prospect Global Resources Inc. • General bldg contractors - residential bldgs
This Agreement relates solely to the Warrants and not to any other Series A Warrants held by the Holder. This Agreement represents the entire understanding and agreement of the parties with respect to the Exercise of the Warrants and supersedes any prior discussions between the parties with respect to any transaction involving the Warrants. Each of the parties hereto shall from time to time execute and deliver all such further documents and do all such further acts and things as the party may reasonably require to effectively carry out or better evidence or perfect the full intent and meaning of this Agreement.
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • January 8th, 2016 • Oxis International Inc • Pharmaceutical preparations • Delaware
This Warrant Exercise Agreement (this “Agreement”) is entered into as of January 7, 2016, by and among OXIS International, Inc., a Delaware corporation (the “Company”), and the parties listed on Schedule A hereto.
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 14th, 2019 • Reebonz Holding LTD • Retail-catalog & mail-order houses • New York
This Warrant Exercise Agreement (this “Agreement”) is dated as of May 14, 2019 (the “Effective Date”), by and between Reebonz Holding Limited, a Cayman Islands exempted company (the “Company”) and the undersigned investor (the “Holder”).
